Publication | Open Access
Phase II trial of gemcitabine and UFT modulated by leucovorin in patients with advanced pancreatic carcinoma
34
Citations
34
References
2000
Year
The combination of gemcitabine-UFT-6SLV is convenient and moderately active and shows a low toxicity for the palliative treatment of patients with APC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1